Πέμπτη 28 Απριλίου 2016

First small molecule targeted therapy to mitigate hearing loss in Usher syndrome type 3

Usher syndrome (USH) is characterized by hearing loss or deafness at birth and progressive vision loss, and is the most common cause of inherited dual sensory deficit.

from #Audiology via xlomafota13 on Inoreader http://ift.tt/1WUyamK
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου